ArticlePloS one2025
Immune landscape and biomarker identification in Q fever: a comprehensive diagnostic analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesQ fever (QF), a zoonotic disease caused by Coxiella burnetii, exhibits highly heterogeneous clinical manifestations-ranging from asymptomatic infection to acute febrile illness and persistent complications. The immune-related molecular mechanisms underlying its diverse disease stages remain incompletely elucidated. This study aimed to dissect the gene expression dynamics across different QF phases via bioinformatics approaches, thereby uncovering key immune-regulatory molecular mechanisms.
methodsGene expression profiles of QF were retrieved from the Gene Expression Omnibus (GEO) database. The CIBERSORT algorithm was employed to quantify the relative proportions of infiltrating immune cells. Temporal gene expression clustering was performed using the mfuzz algorithm to characterize stage-specific immune response patterns. Differentially expressed genes (DEGs) were identified with the limma package, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses to explore their biological functions and associated immune pathways. A protein-protein interaction (PPI) network was constructed to screen for core immune-related genes, and Receiver Operating Characteristic (ROC) curve analysis was utilized to evaluate the diagnostic efficacy of these candidate genes for acute Q fever (AQF).
resultsDistinct immune cell infiltration patterns were observed across QF stages: AQF was characterized by elevated proportions of M1 macrophages and activated natural killer (NK) cells, whereas persistent Q fever (PQF) showed a marked increase in M2 macrophages. Temporal clustering analysis revealed that metabolic-related genes were highly expressed in healthy controls, while both AQF and PQF exhibited dynamic upregulation of genes associated with inflammation and immune regulation. Enrichment analyses indicated that the QF-related immune response was closely linked to COVID-19-associated pathways, Th17 cell differentiation, and cytokine-cytokine receptor signaling. Five hub genes (IL6, IL4, IL1B, AKT1, and CD28) were identified in AQF, all of which demonstrated high diagnostic accuracy with favorable Area Under the Curve (AUC) values.
conclusionThis study delineates the landscape of gene expression and immune status alterations during QF progression. The identified hub genes (IL6, IL4, IL1B, AKT1, and CD28) hold promise as potential diagnostic biomarkers for AQF. Collectively, these findings provide critical insights into the immune-regulatory mechanisms of QF and offer valuable theoretical support for the development of clinical diagnostic tools and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.